Status: Recruiting
A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
This is a two-part study, intended to investigate the safety, tolerability, characteristics of PK and PD of single SC dose of SRSD216 and to identify a dose range for further studies in subjects with elevated Lp(a) level with or without ASCVD history.
Participants needed: 84
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Sirius Therapeutics Co., Ltd.Updated: Jan 6, 2026Locations: 1
Eligibility criteria
Able to comprehend and willing to sign an informed consent form (ICF) and to abi... [+3]
Any history or evidence of abnormal bleeding or coagulopathy; or evidence of pro... [+7]